BOCT Inhibitors
The chemical class of SLC22A17 Inhibitors encompasses compounds that potentially modulate the function of SLC22A17 by influencing related transport mechanisms and cellular pathways. These inhibitors do not directly target SLC22A17 but affect the cellular environment and mechanisms in which SLC22A17 operates.
Compounds such as Probenecid, Cimetidine, and Quinidine are known to inhibit various transporters and could potentially impact SLC22A17's transport function. Verapamil, a calcium channel blocker, and Omeprazole, a proton pump inhibitor, might also influence ion transport processes related to SLC22A17. Other inhibitors, including Ranitidine, Furosemide, Losartan, Ketoconazole, Chlorpromazine, Nicotine, and Amiloride, affect various aspects of cellular transport and signaling pathways. These compounds could indirectly modulate SLC22A17's activity through their impact on related transport mechanisms and cellular processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Known to inhibit various transporters, potentially affecting SLC22A17-mediated transport. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
Inhibits various drug transporters, which might impact SLC22A17 activity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker that can inhibit transporter proteins, potentially affecting SLC22A17. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Inhibits proton pumps and could influence ion transporters related to SLC22A17. | ||||||
Ranitidine | 66357-35-5 | sc-203679 | 1 g | $193.00 | ||
Affects H2 receptors and might indirectly modulate SLC22A17's function. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Known to inhibit a range of transporter proteins, potentially influencing SLC22A17. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
A loop diuretic that can interfere with transporter functions, potentially affecting SLC22A17. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
An angiotensin receptor blocker that may indirectly affect SLC22A17 activity. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Inhibits cytochrome P450 enzymes and might influence SLC22A17-related pathways. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Antipsychotic that affects various transporter activities, potentially including SLC22A17. | ||||||